Copyright
©The Author(s) 2016.
World J Cardiol. Feb 26, 2016; 8(2): 240-246
Published online Feb 26, 2016. doi: 10.4330/wjc.v8.i2.240
Published online Feb 26, 2016. doi: 10.4330/wjc.v8.i2.240
Figure 1 Study selection.
DES: Drug eluting stents.
Figure 2 Definite stent thrombosis.
BMS: Bare metal stents; PP-DES: Permanent polymer drug eluting stents; BD-DES: Biodegradable polymer drug eluting stents.
Figure 3 Target lesion revascularization.
BMS: Bare metal stents; PP-DES: Permanent polymer drug eluting stents; BD-DES: Biodegradable polymer drug eluting stents.
Figure 4 Myocardial infarction.
BMS: Bare metal stents; PP-DES: Permanent polymer drug eluting stents; BD-DES: Biodegradable polymer drug eluting stents.
Figure 5 Cardiac deaths.
BMS: Bare metal stents; PP-DES: Permanent polymer drug eluting stents; BD-DES: Biodegradable polymer drug eluting stents.
- Citation: Pandya B, Gaddam S, Raza M, Asti D, Nalluri N, Vazzana T, Kandov R, Lafferty J. Biodegradable polymer stents vs second generation drug eluting stents: A meta-analysis and systematic review of randomized controlled trials. World J Cardiol 2016; 8(2): 240-246
- URL: https://www.wjgnet.com/1949-8462/full/v8/i2/240.htm
- DOI: https://dx.doi.org/10.4330/wjc.v8.i2.240